IMVT
Immunovant
$38.10
−$0.65 (−1.68%)Sep 10, 2026
Key metrics
The numbers that frame IMVT today
- Market cap
- $7.87B
- P/E (TTM)
- -14.6
- EV / FCF
- -17.1
- ROIC
- 1,761%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $14.58
- 52wk High
- $45.35
Growth
Revenue and earnings trend for IMVT
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about IMVT
Is Immunovant a good buy?
Hold. Immunovant has excellent momentum, but poor quality makes the setup mixed. Growth looks excellent, which supports the long-term business case, but quality and momentum do not clear the bar together. We think Immunovant is selling at a high price.
What is the market capitalization of IMVT?
Immunovant's market capitalization is $7.87B.
What is the P/E ratio for IMVT stock?
Immunovant's current P/E ratio is -14.6.
What is the 52-week high for IMVT stock?
The 52-week high for Immunovant is $45.35. The current close of $38.10 is 16% below that high.
What is the 52-week low for IMVT stock?
The 52-week low for Immunovant is $14.58. The current close of $38.10 is 161.3% above that low.
Does IMVT stock pay dividends?
Immunovant does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for IMVT?
Immunovant's Debt / Equity ratio is 0.